platoseedplatoseed
Diversifying precision cancer diagnostics and treatments
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
Yemaachi Biotech focuses on diversifying cancer diagnostics and therapeutics by building Africa-led clinical genomic research and a diverse cancer bio-database to inform next-generation drugs effective across populations.
The company leverages underrepresented biological and clinical data to drive oncology discoveries and clinical genomic research across Africa, aiming to create globally effective cancer therapeutics. Their approach centers on building a diverse cancer databank and collaborating with partners across public, private, and non-profit sectors to advance precision oncology.
Who it’s for: Pharmaceutical companies, biotechnology developers, and research institutions seeking diverse genomic data and inclusive precision oncology solutions, particularly those prioritizing Africa-related cancer research and global equity in cancer care.
Hiring/traction mentions implied through team and partnerships but no explicit funding or funding rounds listed
With extensive expertise in cellular and molecular immunology, Yaw has a keen interest in immune function as relates to non-communicable diseases among African populations. Yaw is very active in efforts to promote the development of a sustainable research ecosystem across sub-Saharan Africa. He is one of 5 scientists selected in the inaugural round of the prestigious Crick Africa Network Fellowship, an affiliate member of the African Academy of Sciences and a fellow of the Ghana Young Academy.
Finance and Investment professional with experience in investment banking and private equity (covering various sectors) in the US and Africa. Keen interest in high impact businesses. Co-founder and CFO of Yemaachi Biotech.
I am passionate about designing and building tech solutions that are informed by a nuanced understanding of the socio-economic and cultural contexts of the problems. I've worked in the private (Microsoft Research) and non-profit (Grameen Foundation) sectors and built companies that use technology to improve peoples' lives. When I am not hacking ideas or technology, I love to read, travel and experience different cultures. I am always available to play or watch football.
Precision medicine for Africans and the global population
Using the immune system to cure disease
